JP5850517B2 - First agent for hair deformation and hair deformation agent - Google Patents
First agent for hair deformation and hair deformation agent Download PDFInfo
- Publication number
- JP5850517B2 JP5850517B2 JP2010031064A JP2010031064A JP5850517B2 JP 5850517 B2 JP5850517 B2 JP 5850517B2 JP 2010031064 A JP2010031064 A JP 2010031064A JP 2010031064 A JP2010031064 A JP 2010031064A JP 5850517 B2 JP5850517 B2 JP 5850517B2
- Authority
- JP
- Japan
- Prior art keywords
- agent
- hair
- deforming
- deformation
- hair deformation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 174
- VIZXMHCBZLGUET-UHFFFAOYSA-N sodium gualenate Chemical compound CC(C)C1=CC=C(C)C2=C(S(O)(=O)=O)C=C(C)C2=C1 VIZXMHCBZLGUET-UHFFFAOYSA-N 0.000 claims description 41
- 239000003638 chemical reducing agent Substances 0.000 claims description 19
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims description 18
- 239000003093 cationic surfactant Substances 0.000 claims description 14
- 239000002738 chelating agent Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 239000007800 oxidant agent Substances 0.000 claims description 10
- 238000013329 compounding Methods 0.000 claims description 9
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 claims description 8
- 229960002350 guaiazulen Drugs 0.000 claims description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- -1 guaiazulene sulfonates Chemical class 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000002156 mixing Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 229950002760 sodium gualenate Drugs 0.000 description 13
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 238000011282 treatment Methods 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 9
- 239000002612 dispersion medium Substances 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000002260 anti-inflammatory agent Substances 0.000 description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229920003169 water-soluble polymer Polymers 0.000 description 4
- DLLMHEDYJQACRM-UHFFFAOYSA-N 2-(carboxymethyldisulfanyl)acetic acid Chemical compound OC(=O)CSSCC(O)=O DLLMHEDYJQACRM-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- WGVGLSURTKMQQC-UHFFFAOYSA-N 3-aminopropyl-ethyl-dimethylazanium Chemical compound CC[N+](C)(C)CCCN WGVGLSURTKMQQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 2
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- SZEMGTQCPRNXEG-UHFFFAOYSA-M trimethyl(octadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C SZEMGTQCPRNXEG-UHFFFAOYSA-M 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- RTXVDAJGIYOHFY-UHFFFAOYSA-N 2-tetradecyloctadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCC(CO)CCCCCCCCCCCCCC RTXVDAJGIYOHFY-UHFFFAOYSA-N 0.000 description 1
- BQBYBPAPSIWHCE-UHFFFAOYSA-N 5-(dimethylamino)-2-methylpent-2-enoic acid Chemical compound CN(C)CCC=C(C)C(O)=O BQBYBPAPSIWHCE-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- UPFSSYXBJVITGF-USYPQCKVSA-J C(C)(=O)[O-].C(C)(=O)[O-].C(C)(=O)[O-].C(C)(=O)[O-].N[C@@H](CCC(=O)O)C(=O)O.[Na+].[Na+].[Na+].[Na+] Chemical compound C(C)(=O)[O-].C(C)(=O)[O-].C(C)(=O)[O-].C(C)(=O)[O-].N[C@@H](CCC(=O)O)C(=O)O.[Na+].[Na+].[Na+].[Na+] UPFSSYXBJVITGF-USYPQCKVSA-J 0.000 description 1
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 1
- 229940123150 Chelating agent Drugs 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000530 carbenoxolone Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960004585 etidronic acid Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000010409 ironing Methods 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- KKBOOQDFOWZSDC-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KKBOOQDFOWZSDC-UHFFFAOYSA-N 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002523 polyethylene Glycol 1000 Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- RUTSRVMUIGMTHJ-UHFFFAOYSA-M sodium;tetradec-1-ene-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCC=CS([O-])(=O)=O RUTSRVMUIGMTHJ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229940105956 tea-dodecylbenzenesulfonate Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- XWNXEWLCHSLQOI-UHFFFAOYSA-K trisodium;triacetate Chemical compound [Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O XWNXEWLCHSLQOI-UHFFFAOYSA-K 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
Description
本発明は、パーマネントウェーブ処理や縮毛矯正処理などの毛髪の変形処理に用いられる毛髪変形用第１剤および毛髪変形剤に関するものである。 The present invention relates to a first hair deformation agent and a hair deformation agent used for hair deformation treatment such as permanent wave treatment and curly hair straightening treatment.
パーマネントウェーブや縮毛矯正といった毛髪変形処理は、還元剤を含む第１剤を用いて毛髪中のシスチン結合を還元し、所望の状態とした後に酸化剤を含む第２剤を用いたり、空気酸化によってその状態を固定する化学的処理である。 Hair deformation treatments such as permanent wave and curly hair correction use a first agent containing a reducing agent to reduce the cystine bond in the hair and bring it to the desired state, and then use a second agent containing an oxidizing agent or air oxidation. It is a chemical treatment that fixes the state by.
こうした毛髪変形剤では、第１剤と第２剤との誤使用を防止したり、第１剤や第２剤が適用する髪質に応じて複数のグレードがある場合に、それぞれの識別性を高めたりするために、第１剤や第２剤を色素によって着色する工夫がなされている。 In such a hair deforming agent, it is possible to prevent misuse of the first agent and the second agent, and when there are multiple grades depending on the hair quality applied by the first agent and the second agent, In order to increase it, the device which colors the 1st agent and the 2nd agent with a pigment is made.
例えば、医薬分野において、抗炎症作用を有する有効成分として用いられているグアイアズレンスルホン酸ナトリウムなどのグアイアズレンスルホン酸塩は、薬剤に青色から青紫色を付け得る天然色素としても知られている。 For example, guaiazulene sulfonates such as sodium guaiazulene sulfonate used as an active ingredient having an anti-inflammatory action in the pharmaceutical field are also known as natural pigments that can add blue to blue-violet to drugs.
ところが、グアイアズレンスルホン酸塩は、光や熱に対して不安定で、容易に分解してしまうといった欠点も有しており、その際に色も消失してしまう。このようなことから、グアイアズレンスルホン酸塩を含有する液剤において、光や熱によるグアイアズレンスルホン酸塩の分解を抑制する技術が提案されている（例えば特許文献１）。 However, guaiazulene sulfonate has the disadvantage that it is unstable to light and heat and easily decomposes, and the color disappears at that time. For this reason, a technique for suppressing decomposition of guaiazulene sulfonate by light or heat in a liquid agent containing guaiazulene sulfonate has been proposed (for example, Patent Document 1).
本発明者らは、グアイアズレンスルホン酸塩を毛髪変形用第１剤に配合して、グアイアズレンスルホン酸塩由来の青色に着色する検討を開始した。ところが、医薬分野で採用されているような組成の液剤中では、グアイアズレンスルホン酸塩は熱に対して不安定で、温度が高くなるほど分解しやすいのに対し、還元剤を含有する毛髪変形用第１剤中では、これとは全く異なる挙動を示すことが判明した。具体的には、グアイアズレンスルホン酸塩を還元剤とともに含有する毛髪変形用第１剤では、例えば５０℃程度に加熱しつつ２週間程度保存しても、グアイアズレンスルホン酸塩由来の青色が殆ど消失しない一方で、室温下で２週間程度保存すると、グアイアズレンスルホン酸塩由来の青色が消失してしまう。 The inventors of the present invention have begun studying coloring guaiazulene sulfonate from blue color derived from guaiazulene sulfonate by blending guaiazulene sulfonate with the first hair deformation agent. However, in liquids having a composition as used in the pharmaceutical field, guaiazulene sulfonate is unstable to heat and easily decomposes as the temperature rises. It was found that one agent showed completely different behavior. Specifically, in the first hair deformation agent containing guaiazulene sulfonate together with a reducing agent, the blue color derived from guaiazulene sulfonate hardly disappears even when stored for about 2 weeks while being heated to about 50 ° C., for example. On the other hand, when it is stored at room temperature for about 2 weeks, the blue color derived from guaiazulene sulfonate disappears.
また、グアイアズレンスルホン酸塩の光や熱に対する安定性を高めた従来の液剤を用いて毛髪変形用第１剤を調製しても、グアイアズレンスルホン酸塩由来の青色を良好に保持することが困難であることも、本発明者らの検討により明らかとなった。 In addition, even when the first agent for hair deformation is prepared using a conventional liquid agent that improves the stability of guaiazulene sulfonate to light and heat, it is difficult to maintain the blue color derived from guaiazulene sulfonate well. This has also been clarified by the study of the present inventors.
本発明は、上記事情に鑑みてなされたものであり、その目的は、グアイアズレンスルホン酸塩由来の色を良好に保持し得る毛髪変形用第１剤と、該毛髪変形用第１剤により構成される毛髪変形剤とを提供することにある。 The present invention has been made in view of the above circumstances, and its object is composed of a first agent for deforming hair that can satisfactorily retain a color derived from guaiazulene sulfonate, and the first agent for deforming hair. Providing a hair deforming agent.
上記目的を達成し得た本発明の毛髪変形用第１剤は、少なくとも、（ａ）グアイアズレンスルホン酸塩、（ｂ）還元剤、（ｃ）アルカリ剤、（ｄ）カチオン性界面活性剤、および（ｅ）キレート剤が配合されたことを特徴とするものである。 The first agent for hair deformation of the present invention that can achieve the above-described object is at least (a) guaiazulene sulfonate, (b) a reducing agent, (c) an alkali agent, (d) a cationic surfactant, and (E) A chelating agent is blended.
また、本発明の毛髪変形剤は、本発明の毛髪変形用第１剤と、酸化剤が少なくとも配合された毛髪変形用第２剤とで構成されたことを特徴とするものである。 The hair deforming agent of the present invention is characterized by comprising the first agent for deforming hair of the present invention and the second agent for deforming hair in which at least an oxidizing agent is blended.
本発明によれば、グアイアズレンスルホン酸塩由来の色を安定に保持し得る毛髪変形用第１剤と、該毛髪変形用第１剤により構成される毛髪変形剤とを提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the hair deformation 1st agent which can hold | maintain the color derived from a guaiazulenesulfonate stably, and the hair deformation agent comprised by this 1st agent for hair deformation can be provided.
本発明の毛髪変形用第１剤は、（ａ）グアイアズレンスルホン酸塩、（ｂ）還元剤、（ｃ）アルカリ剤、（ｄ）カチオン性界面活性剤、および（ｅ）キレート剤が配合されたものであることを特徴としており、本発明の毛髪変形用第１剤を塗布し、その後に酸化剤が少なくとも配合された毛髪変形用第２剤を塗布するか、または空気中の酸素によって、毛髪に変形処理を施すためのものである。すなわち、本発明の毛髪変形用第１剤は、それのみで毛髪変形剤として機能する態様と、酸化剤が配合された毛髪変形用第２剤と組み合わせて毛髪変形剤を構成する態様とを含む。 The first agent for deforming hair of the present invention was formulated with (a) guaiazulene sulfonate, (b) a reducing agent, (c) an alkali agent, (d) a cationic surfactant, and (e) a chelating agent. The first hair deformation agent of the present invention is applied, and then the second hair deformation agent containing at least an oxidizing agent is applied, or the hair is subjected to oxygen in the air. This is for subjecting to deformation processing. That is, the first agent for deforming hair of the present invention includes an embodiment that functions as a hair deforming agent by itself, and an embodiment that constitutes a hair deforming agent in combination with the second agent for deforming hair that contains an oxidizing agent. .
（ａ）成分であるグアイアズレンスルホン酸塩は、毛髪変形用第１剤を着色するための成分であり、これを配合することにより、毛髪変形用第１剤が青色を呈するようになる。よって、例えば毛髪変形用第２剤と色を変えたり、毛髪変形力の異なる毛髪変形用第１剤同士で色を変えることが可能となり、これらの間での誤使用を防止することができる。また、グアイアズレンスルホン酸塩は抗炎症作用も有しており、毛髪変形用第１剤において抗炎症剤としても機能する。 The guaiazulene sulfonate which is the component (a) is a component for coloring the first agent for deforming hair, and by blending this, the first agent for deforming hair becomes blue. Therefore, for example, it becomes possible to change a color with the 2nd agent for hair deformation, or to change a color between the 1st agent for hair deformation from which hair deformation force differs, and to prevent misuse between these. In addition, guaiazulene sulfonate has an anti-inflammatory action and functions as an anti-inflammatory agent in the first hair deformation agent.
ただし、上記の通り、グアイアズレンスルホン酸塩を配合し、更に（ｂ）成分である還元剤を配合した毛髪変形用第１剤では、グアイアズレンスルホン酸塩由来の色を安定に保持し難く、容易に色が消失して白色または無色（透明）になったり、グアイアズレンスルホン酸塩由来の色以外の色を呈するようになったりする場合がある。 However, as described above, in the first agent for deforming hair that contains guaiazulene sulfonate and further contains the reducing agent (b), it is difficult to stably maintain the color derived from guaiazulene sulfonate. The color may disappear and become white or colorless (transparent), or may exhibit a color other than the color derived from guaiazulene sulfonate.
そこで、本発明の毛髪変形用第１剤では、（ａ）グアイアズレンスルホン酸塩や、毛髪変形用第１剤に必須の成分である（ｂ）還元剤および（ｃ）アルカリ剤に加えて、（ｄ）カチオン性界面活性剤および（ｅ）キレート剤を配合することとし、これらの作用によって、毛髪変形用第１剤におけるグアイアズレンスルホン酸塩由来の色を良好に保持できるようにした。 Therefore, in the first agent for hair deformation of the present invention, in addition to (a) guaiazulene sulfonate and (b) reducing agent and (c) alkali agent which are essential components for the first agent for hair deformation, d) A cationic surfactant and (e) a chelating agent were added, and by these actions, the color derived from guaiazulene sulfonate in the first agent for deforming hair could be maintained well.
（ａ）成分であるグアイアズレンスルホン酸塩としては、例えば、グアイアズレンスルホン酸のナトリウム塩（グアイアズレンスルホン酸ナトリウム）やカリウム塩（グアイアズレンスルホン酸カリウム）などが挙げられる。 Examples of the guaiazulene sulfonate that is component (a) include sodium salt of guaiazulene sulfonic acid (sodium guaiazulene sulfonate) and potassium salt (potassium guaiazulene sulfonate).
毛髪変形用第１剤における（ａ）成分であるグアイアズレンスルホン酸塩の配合量は、その使用による効果を良好に確保する観点から、０．００１質量％以上であることが好ましい。ただし、（ａ）成分は、多量に配合しても効果が飽和する他、非常に高価な材料であることから、多量に配合すると毛髪変形用第１剤のコストが増大してしまう。よって、毛髪変形用第１剤における（ａ）成分の配合量は、０．０５質量％以下であることが好ましい。 It is preferable that the compounding quantity of the guaiazulene sulfonate which is (a) component in the 1st agent for hair deformation is 0.001 mass% or more from a viewpoint of ensuring the effect by the use favorable. However, the effect of the component (a) is saturated even when blended in a large amount, and since it is a very expensive material, the amount of the first agent for deforming hair increases when blended in a large amount. Therefore, it is preferable that the compounding quantity of (a) component in the 1st agent for hair deformation is 0.05 mass% or less.
毛髪変形用第１剤における（ｂ）成分である還元剤としては、毛髪中のタンパク質であるケラチンを還元する能力のあるものであれば特に制限はなく、チオグリコール酸またはその塩（アンモニウム塩、モノエタノールアミン塩など）、システインやその誘導体およびそれらの塩（塩酸塩など）、亜硫酸塩、亜硫酸水素塩など、メルカプト基を有する種々の還元剤が挙げられ、これらを１種単独で用いてもよく、これらのうちの２種以上を併用してもよい。これらの中でも、グアイアズレンスルホン酸塩由来の色の消失が著しいチオグリコール酸またはその塩や亜流酸塩の場合には、本発明の効果が特に顕著となる。 The reducing agent as the component (b) in the first hair deformation agent is not particularly limited as long as it has the ability to reduce keratin, which is a protein in hair, and thioglycolic acid or a salt thereof (ammonium salt, Monoethanolamine salts, etc.), cysteine and its derivatives and salts thereof (hydrochlorides, etc.), sulfites, bisulfites, and the like, and various reducing agents having a mercapto group can be used. Of these, two or more of these may be used in combination. Among these, in the case of thioglycolic acid or a salt or sulfite thereof in which the disappearance of the color derived from guaiazulene sulfonate is remarkable, the effect of the present invention is particularly remarkable.
毛髪変形用第１剤における（ｂ）成分の配合量は、要求される還元力に応じて適宜調整すればよいが、チオグリコール酸換算値で、例えば、１〜１６質量％であることが好ましい。なお、ここでいう毛髪変形用第１剤における還元剤の配合量に係る「チオグリコール酸換算値」は、パーマネント・ウェーブ工業組合から発行されている「パーマネント・ウェーブ用剤製造（輸入）承認基準」の「［別添］パーマネント・ウェーブ用剤品質規格」の「１．チオグリコール酸又はその塩類を有効成分とするコールド二溶式パーマネント・ウェーブ溶剤」における「（１）第１剤」に記載の「（ウ）酸性煮沸後の還元性物質」に定められている手法によって求められる「酸性煮沸後の還元性物質の含有率（チオグリコール酸として）（％）」である。 The blending amount of the component (b) in the first hair deformation agent may be appropriately adjusted according to the required reducing power, but is preferably 1 to 16% by mass in terms of thioglycolic acid. . The “thioglycolic acid equivalent value” related to the amount of reducing agent in the first hair deformation agent referred to here is the “Permanent Wave Manufacturing (Import) Approval Standard” issued by the Permanent Wave Industry Association. "[Appendix] Permanent Wave Agent Quality Standard" in "1. Cold Dissolved Permanent Wave Solvents with Thioglycolic Acid or its Salts as Active Ingredients" in "(1) First Agent" "(C) Content of reducing substance after acid boiling (as thioglycolic acid) (%)" determined by the method defined in "(c) Reducing substance after acid boiling".
毛髪変形用第１剤における（ｃ）成分であるアルカリ剤としては、アルカリ能を有するものであれば特に制限はなく、例えば、アンモニア、アミン類、中性塩タイプのアルカリ剤、塩基性アミノ酸などが挙げられる。アミン類としては、例えば、モノエタノールアミン、イソプロパノールアミンなどが挙げられる。また、中性塩タイプのアルカリ剤としては、例えば、炭酸水素アンモニウム、炭酸水素ナトリウム、リン酸水素アンモニウムなどが挙げられる。塩基性アミノ酸としては、例えば、リジン、アルギニンが挙げられる。（ｃ）成分であるアルカリ剤は１種単独で用いてもよく、２種以上を併用しても構わない。 The alkaline agent that is the component (c) in the first hair deformation agent is not particularly limited as long as it has alkaline ability. For example, ammonia, amines, neutral salt type alkaline agents, basic amino acids, etc. Is mentioned. Examples of amines include monoethanolamine and isopropanolamine. Examples of the neutral salt type alkaline agent include ammonium hydrogen carbonate, sodium hydrogen carbonate, ammonium hydrogen phosphate, and the like. Examples of basic amino acids include lysine and arginine. (C) The alkali agent which is a component may be used individually by 1 type, and may use 2 or more types together.
毛髪変形用第１剤における（ｃ）成分の配合量は、グアイアズレンスルホン酸塩由来の色を良好に保持する点から、毛髪変形用第１剤のｐＨを７〜１２に調整できる量とすればよく、毛髪変形用第１剤のｐＨを８〜１０に調整できる量とすることがより好ましい。 If the blending amount of the component (c) in the first hair deformation agent is such that the pH of the first hair deformation agent can be adjusted to 7 to 12 from the point that the color derived from guaiazulene sulfonate is satisfactorily maintained. It is more preferable that the pH of the first agent for deforming hair is adjusted to 8 to 10.
毛髪変形用第１剤における（ｄ）成分であるカチオン性界面活性剤および（ｅ）成分であるキレート剤は、上記の通り、（ａ）成分であるグアイアズレンスルホン酸塩由来の色を保持する作用を有している。すなわち、グアイアズレンスルホン酸塩とともに、カチオン性界面活性剤およびキレート剤を毛髪変形用第１剤に配合することで、グアイアズレンスルホン酸塩由来の色の消失と、グアイアズレンスルホン酸塩由来の色とは異なる色となることを抑制できる。 The cationic surfactant that is component (d) and the chelating agent that is component (e) in the first hair deformation agent, as described above, retain the color derived from guaiazulene sulfonate that is component (a). have. That is, the disappearance of the color derived from guaiazulene sulfonate and the color derived from guaiazulene sulfonate are different by adding a cationic surfactant and a chelating agent to the first agent for hair deformation together with guaiazulene sulfonate. It can suppress becoming a color.
（ｄ）成分であるカチオン性界面活性剤としては、公知の各種化粧料で用いられているカチオン性界面活性剤から選択した１種または２種以上を用いることができる。（ｄ）成分の具体例としては、例えば、脂肪酸アミドアミン塩、モノアルキル型４級アンモニウム塩、ジアルキル型４級アンモニウム塩、ベンザルコニウム型４級アンモニウム、エチル硫酸ラノリン脂肪酸アミノプロピルエチルジメチルアンモニウムなどが挙げられる。脂肪酸アミドアミン塩としては、例えば、ステアリン酸ジエチルアミノエチルアミド、ステアリン酸ジメチルアミノプロピルアミドなどが挙げられる。モノアルキル型４級アンモニウム塩としては、例えば、塩化ラウリルトリメチルアンモニウム、塩化セチルトリメチルアンモニウム、塩化ステアリルトリメチルアンモニウム、塩化ベヘニルトリメチルアンモニウム、臭化ラウリルトリメチルアンモニウム、臭化セチルトリメチルアンモニウム、臭化ステアリルトリメチルアンモニウムなどが挙げられる。ジアルキル型４級アンモニウム塩としては、例えば、塩化ジステアリルジメチルアンモニウム、塩化ジココイルジメチルアンモニウム、塩化ジセチルジメチルアンモニウムなどが挙げられる。ベンザルコニウム型４級アンモニウムとしては、例えば、塩化ベンザルコニウム、塩化ステアリルジメチルベンジルアンモニウムなどが挙げられる。 As the cationic surfactant which is component (d), one or more selected from cationic surfactants used in various known cosmetics can be used. Specific examples of the component (d) include fatty acid amidoamine salts, monoalkyl type quaternary ammonium salts, dialkyl type quaternary ammonium salts, benzalkonium type quaternary ammonium, ethyl lanolin sulfate fatty acid aminopropylethyldimethylammonium and the like. Can be mentioned. Examples of fatty acid amide amine salts include stearic acid diethylaminoethylamide and stearic acid dimethylaminopropylamide. Examples of the monoalkyl type quaternary ammonium salt include lauryl trimethyl ammonium chloride, cetyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, behenyl trimethyl ammonium chloride, lauryl trimethyl ammonium bromide, cetyl trimethyl ammonium bromide, stearyl trimethyl ammonium bromide and the like. Is mentioned. Examples of the dialkyl type quaternary ammonium salt include distearyl dimethyl ammonium chloride, dicocoyl dimethyl ammonium chloride, dicetyl dimethyl ammonium chloride, and the like. Examples of the benzalkonium-type quaternary ammonium include benzalkonium chloride and stearyldimethylbenzylammonium chloride.
毛髪変形用第１剤において、（ｄ）成分であるカチオン性界面活性剤の配合量は、その使用による効果（特に、グアイアズレンスルホン酸塩由来の色の消失を抑制する効果）をより良好に確保する観点から、モル基準で、（ａ）成分であるグアイアズレンスルホン酸塩の配合量１に対して、１以上であることが好ましい［すなわち、（ａ）成分の配合量が１モルの場合、（ｄ）成分の配合量は、１モル以上であることが好ましい］。 In the first agent for deforming hair, the amount of the cationic surfactant as component (d) ensures a better effect (especially the effect of suppressing the disappearance of the color derived from guaiazulene sulfonate). From the viewpoint of, it is preferable that it is 1 or more with respect to the blending amount 1 of the guaiazulene sulfonate which is the component (a) on a molar basis [that is, when the blending amount of the component (a) is 1 mole The blending amount of component d) is preferably 1 mol or more.
なお、毛髪変形用第１剤が乳化物で、乳化剤として（ｄ）成分を使用している場合、乳化剤として作用している（ｄ）成分は、グアイアズレンスルホン酸塩由来の色の安定化には殆ど寄与しない。よって、（ｄ）成分を乳化剤としても毛髪変形用第１剤に配合する場合には、毛髪変形用第１剤の調製にあたり、（ａ）成分であるグアイアズレンスルホン酸塩と（ｄ）成分とを、予め混合しておくことが好ましく、その際の（ａ）成分と（ｄ）成分との混合比率が、前記好適値となるように調整することが推奨される。 When the first agent for deforming hair is an emulsion and component (d) is used as an emulsifier, component (d) acting as an emulsifier is used to stabilize the color derived from guaiazulene sulfonate. Hardly contributes. Therefore, when the component (d) is used as an emulsifier in the first agent for deforming hair, the preparation of the first agent for deforming hair includes (a) guaiazulene sulfonate and (d) component. It is preferable to mix in advance, and it is recommended that the mixing ratio of the component (a) and the component (d) at that time be adjusted to the above-mentioned suitable value.
ただし、毛髪変形用第１剤における（ｄ）成分の配合量が多すぎると、塗布後の毛髪がべたつきやすくなることから、毛髪変形用第１剤における（ｄ）成分の配合量は、８質量％以下とすることが好ましい。 However, if the blending amount of the component (d) in the first agent for deforming hair is too much, the hair after application becomes easy to stick. Therefore, the blending amount of the component (d) in the first agent for deforming hair is 8 mass. % Or less is preferable.
（ｅ）成分であるキレート剤としては、公知の化粧料で用いられているキレート剤から選択した１種または２種以上を用いることができる。（ｅ）成分の具体例としては、例えば、エデト酸、エデト酸二ナトリウム、クエン酸ナトリウム、酒石酸、フィチン酸、ヒドロキシエタンジホスホン酸またはその塩、ジエチレントリアミン五酢酸五ナトリウム、Ｌ−アスパラギン酸−Ｎ，Ｎ−二酢酸四ナトリウム、エチレンジアミンヒドロキシエチル三酢酸三ナトリウム、Ｌ−グルタミン酸二酢酸四ナトリウムなどが挙げられる。 As the chelating agent as the component (e), one or more selected from chelating agents used in known cosmetics can be used. Specific examples of the component (e) include, for example, edetic acid, disodium edetate, sodium citrate, tartaric acid, phytic acid, hydroxyethanediphosphonic acid or a salt thereof, diethylenetriaminepentaacetic acid pentasodium, L-aspartic acid-N. N-tetraacetic acid tetrasodium, ethylenediaminehydroxyethyl triacetate trisodium, L-glutamic acid tetrasodium tetraacetate and the like.
毛髪変形用第１剤におけるキレート剤の配合量は、その使用による効果（特に、グアイアズレンスルホン酸塩由来の色とは異なる色となることを抑制する効果）をより良好に確保する観点から、０．００５質量％以上であることが好ましく、０．０１質量％以上であることがより好ましい。また、毛髪変形用第１剤におけるキレート剤の配合量を多くしすぎると、塗布後の毛髪の感触が低下する傾向があることから、その配合量は、５質量％以下であることが好ましい。 The compounding amount of the chelating agent in the first hair deformation agent is 0 from the viewpoint of better ensuring the effect of its use (in particular, the effect of suppressing the color from being different from the color derived from guaiazulene sulfonate). It is preferably 0.005% by mass or more, and more preferably 0.01% by mass or more. Moreover, since there exists a tendency for the touch of the hair after application | coating to fall when the compounding quantity of the chelating agent in the 1st agent for hair deformation is increased too much, it is preferable that the compounding quantity is 5 mass% or less.
毛髪変形用第１剤は、水を主たる分散媒とする。なお、前記の各種成分の一部は、水に溶解していてもよい。また、分散媒には、水のみを用いてもよく、必要に応じて、エタノール、イソプロパノールなどの低級アルコール（炭素数が６以下のアルコール）などの有機溶媒を、分散媒全量中５質量％以下程度の量で水と併用してもよい。また、毛髪変形用第１剤における分散媒の配合量は、例えば、４０〜９８質量％であることが好ましい。 The 1st agent for hair deformation uses water as the main dispersion medium. In addition, some of the various components may be dissolved in water. Further, only water may be used as the dispersion medium. If necessary, an organic solvent such as a lower alcohol (alcohol having 6 or less carbon atoms) such as ethanol or isopropanol is used in an amount of 5% by mass or less based on the total amount of the dispersion medium. It may be used in combination with water in a certain amount. Moreover, it is preferable that the compounding quantity of the dispersion medium in the 1st agent for hair deformation is 40-98 mass%, for example.
また、毛髪変形用第１剤には、反応調整剤として、ジチオジグリコール酸類［ジチオジグリコール酸や、ジチオジグリコール酸の塩（ジアンモニウム塩、ジモノエタノールアミン塩、ジトリエタノールアミン塩など）］を配合することが好ましい。毛髪変形用第１剤におけるジチオジグリコール酸類の配合量は、０．１〜４質量％であることが好ましい。 In addition, the first agent for deforming hair uses dithiodiglycolic acids [dithiodiglycolic acid and dithiodiglycolic acid salts (diammonium salt, dimonoethanolamine salt, ditriethanolamine salt, etc.) as reaction modifiers. ] Is preferably blended. The blending amount of dithiodiglycolic acid in the first hair deformation agent is preferably 0.1 to 4% by mass.
更に、毛髪変形用第１剤は、前記の各構成成分の他に、従来から知られている毛髪変形剤（パーマネントウェーブ用剤、縮毛矯正用剤）や、その他の毛髪用の化粧剤などに添加されている各種添加剤を配合することができる。このような添加剤としては、例えば、油脂、高級アルコール類、シリコーン類、水溶性高分子、保湿剤、界面活性剤（アニオン性界面活性剤、非イオン性界面活性剤、両性界面活性剤）、抗炎症剤［（ａ）成分以外のもの］、防腐剤、ｐＨ調整剤［（ｃ）成分以外のもの］紫外線吸収剤、香料などが挙げられる。 Furthermore, the first agent for deforming hair is the conventionally known hair deforming agent (permanent wave agent, curly hair straightening agent), other hair cosmetic agents, etc. Various additives added to can be blended. Examples of such additives include fats and oils, higher alcohols, silicones, water-soluble polymers, humectants, surfactants (anionic surfactants, nonionic surfactants, amphoteric surfactants), Examples include anti-inflammatory agents [other than the component (a)], preservatives, pH adjusters [other than the component (c)] ultraviolet absorbers, fragrances, and the like.
油脂としては、例えば、ヒマシ油、オリーブ油、ツバキ油、マカデミアナッツ油、グレープシード油、ミンク油、卵黄油、カカオ脂、ヤシ脂、パーム油、モクロウ、アボカド油、シア脂などが挙げられる。高級アルコールとしては、例えば、ラウリルアルコール、ミリスチルアルコール、セタノール、ステアリルアルコ−ル、オクチルドデカノール、ベヘニルアルコール、イソセチルアルコール、イソステアリルアルコール、デシルテトラデカノール、テトラデシルオクタデカノール、セテアリルアルコール、オレイルアルコール、ホホバアルコール、ラノリンアルコールなどが挙げられる。なお、高級アルコールの炭素数は、２４以下であることが好ましい。 Examples of the fat include castor oil, olive oil, camellia oil, macadamia nut oil, grape seed oil, mink oil, egg yolk oil, cocoa butter, coconut butter, palm oil, molasses, avocado oil, and shea fat. Examples of the higher alcohol include lauryl alcohol, myristyl alcohol, cetanol, stearyl alcohol, octyldodecanol, behenyl alcohol, isocetyl alcohol, isostearyl alcohol, decyltetradecanol, tetradecyloctadecanol, cetearyl alcohol, oleyl Alcohol, jojoba alcohol, lanolin alcohol, etc. are mentioned. The higher alcohol preferably has 24 or less carbon atoms.
シリコーン類としては、例えば、ジメチルシリコーン、高重合ジメチルシリコーン、環状シリコーン、ポリエーテル変性シリコーン、アミノ変性シリコーン（アミノエチルアミノプロピルシロキサン・ジメチルシロキサン共重合体、アミノエチルアミノプロピルメチルシロキサン・ジメチルシロキサン共重合体、アミノエチルアミノプロピルメチルポリシロキサン・ジメチルポリシロキサン共重合体など）などが挙げられる。水溶性高分子としては、例えば、カチオン化セルロース、カチオン化グアーガム、ビニルピロリドン・Ｎ，Ｎ−ジメチルアミノエチルメタクリル酸共重合体ジエチル硫酸塩、アクリルアミド・アクリル酸・塩化ジメチルジアリルアンモニウム共重合体などが挙げられる。保湿剤としては、例えば、グリセリン、ジグリセリン、プロピレングリコール、１，３−ブチレングリコール、ジプロピレングリコール、ピロリドンカルボン酸ナトリウム、ヒアルロン酸、ソルビトール、トレハロース、高重合ポリエチレングリコールなどが挙げられる。 Examples of silicones include dimethyl silicone, highly polymerized dimethyl silicone, cyclic silicone, polyether-modified silicone, amino-modified silicone (aminoethylaminopropylsiloxane / dimethylsiloxane copolymer, aminoethylaminopropylmethylsiloxane / dimethylsiloxane copolymer). And an aminoethylaminopropylmethylpolysiloxane / dimethylpolysiloxane copolymer). Examples of water-soluble polymers include cationized cellulose, cationized guar gum, vinylpyrrolidone / N, N-dimethylaminoethyl methacrylic acid copolymer diethyl sulfate, acrylamide / acrylic acid / dimethyldiallylammonium chloride copolymer, and the like. Can be mentioned. Examples of the humectant include glycerin, diglycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, sodium pyrrolidonecarboxylate, hyaluronic acid, sorbitol, trehalose, and highly polymerized polyethylene glycol.
アニオン性界面活性剤としては、例えば、ラウリル硫酸ナトリウム、ポリオキシエチレンラウリルエーテル硫酸ナトリウム、ステアロイルメチルタウリンナトリウム、ドデシルベンゼンスルホン酸トリエタノールアミン、テトラデセンスルホン酸ナトリウムなどが挙げられる。カチオン性界面活性剤としては、例えば、塩化ラウリルトリメチルアンモニウム、塩化ステアリルトリメチルアンモニウムなどの塩化アルキルトリメチルアンモニウム、塩化ジステアリルジメチルアンモニウム、臭化セチルトリメチルアンモニウム、臭化ステアリルトリメチルアンモニウム、ステアリルトリメチルアンモニウムサッカリン、エチル硫酸ラノリン脂肪酸アミノプロピルエチルジメチルアンモニウムなどが挙げられる。 Examples of the anionic surfactant include sodium lauryl sulfate, sodium polyoxyethylene lauryl ether sulfate, sodium stearoylmethyl taurate, triethanolamine dodecylbenzenesulfonate, sodium tetradecenesulfonate, and the like. Examples of the cationic surfactant include alkyltrimethylammonium chloride such as lauryltrimethylammonium chloride and stearyltrimethylammonium chloride, distearyldimethylammonium chloride, cetyltrimethylammonium bromide, stearyltrimethylammonium bromide, stearyltrimethylammonium saccharin, ethyl Examples include lanolin sulfate fatty acid aminopropylethyldimethylammonium.
非イオン性界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル類（ポリオキシエチレンステアリルエーテル、ポリオキシエチレンセチルエーテル、ポリオキシエチレンラウリルエーテルなど）、ポリオキシエチレンアルキルフェニルエーテル類、ポリオキシエチレンポリオキシプロピレンアルキルエーテル（ポリオキシエチレンポリオキシプロピレンセチルエーテル、ポリオキシエチレンポリオキシプロピレンベヘニルエーテル、ポリオキシエチレンポリオキシプロピレン２−デシルテトラデシルエーテル、ポリオキシエチレンポリオキシプロピレンブチルエーテル、ポリオキシエチレンポリオキシプロピレン水添ラノリン、ポリオキシエチレンポリオキシプロピレングリセリンエーテルなど）、ポリオキシエチレンポリオキシプロピレングリコール、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル（モノステアリン酸ソルビタンなど）、モノラウリン酸ポリオキシエチレンソルビタン、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシアルキレンベンジルエーテル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ショ糖脂肪酸エステル、アルキルポリグリコシド、Ｎ−アルキルジメチルアミンオキシド、ポリオキシエチレンプロピレングリコール脂肪酸エステルなどが挙げられる。両性界面活性剤としては、例えば、コカミドプロピルベタイン、ラウリルジメチルアミノ酢酸ベタイン、ラウラミドプロピルベタイン、２−アルキル−Ｎ−カルボキシメチル−Ｎ−ヒドロキシエチルイミダゾリニウムベタインなどが挙げられる。 Nonionic surfactants include, for example, polyoxyethylene alkyl ethers (polyoxyethylene stearyl ether, polyoxyethylene cetyl ether, polyoxyethylene lauryl ether, etc.), polyoxyethylene alkyl phenyl ethers, polyoxyethylene poly Oxypropylene alkyl ether (polyoxyethylene polyoxypropylene cetyl ether, polyoxyethylene polyoxypropylene behenyl ether, polyoxyethylene polyoxypropylene 2-decyltetradecyl ether, polyoxyethylene polyoxypropylene butyl ether, polyoxyethylene polyoxypropylene Hydrogenated lanolin, polyoxyethylene polyoxypropylene glycerin ether, etc.), polyoxyethylene polio Cypropylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sorbitan fatty acid ester (such as sorbitan monostearate), polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan fatty acid ester, polyoxyalkylene benzyl ether, polyoxyethylene castor oil, Examples thereof include polyoxyethylene hydrogenated castor oil, sucrose fatty acid ester, alkyl polyglycoside, N-alkyldimethylamine oxide, polyoxyethylene propylene glycol fatty acid ester and the like. Examples of the amphoteric surfactant include cocamidopropyl betaine, lauryldimethylaminoacetic acid betaine, lauramidopropyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine.
（ａ）成分以外の抗炎症剤としては、例えば、グリチルリチン酸ジカリウム、カルベノキソロン二ナトリウムなどが挙げられる。防腐剤としては、例えば、安息香酸ナトリウム、ソルビン酸、ソルビン酸カリウム、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチル、フェノキシエタノールなどが挙げられる。ｐＨ調整剤としては、例えば、リン酸、リン酸二水素ナトリウム、リン酸一水素二ナトリウムなどが挙げられる。紫外線吸収剤としては、例えば、ヒドロキシメトキシベンゾフェノンスルホン酸などが挙げられる。 Examples of anti-inflammatory agents other than the component (a) include dipotassium glycyrrhizinate and carbenoxolone disodium. Examples of the preservative include sodium benzoate, sorbic acid, potassium sorbate, methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, butyl paraoxybenzoate, and phenoxyethanol. Examples of the pH adjuster include phosphoric acid, sodium dihydrogen phosphate, disodium monohydrogen phosphate, and the like. Examples of the ultraviolet absorber include hydroxymethoxybenzophenone sulfonic acid.
毛髪変形用第１剤は、例えば、クリーム状、乳液状、ゲル状、ローション状などの形態とすることができる。例えば、毛髪への塗布性の点からは、パーマネントウェーブ用第１剤とする場合はローション状が好ましく、縮毛矯正用第１剤とする場合はクリーム状が好ましい。 The 1st agent for hair deformation can be made into forms, such as cream form, emulsion, gel form, and lotion form, for example. For example, from the viewpoint of applicability to hair, when it is used as the first agent for permanent wave, a lotion shape is preferable, and when it is used as the first agent for straightening hair, a cream shape is preferable.
上記の通り、本発明の毛髪変形用第１剤は、それのみで毛髪変形剤を構成することができ、その場合、毛髪変形用第１剤塗布後の毛髪の形状の固定は、空気中の酸素による酸化で行う。また、本発明の毛髪変形用第１剤は、毛髪変形用第２剤と組み合わせて使用することもでき、これらを組み合わせて毛髪変形剤（本発明の毛髪変形剤）を構成することもできる。本発明の毛髪変形用第１剤と組み合わせ得る毛髪変形用第２剤としては、例えば以下のものが挙げられる。 As described above, the first hair deformation agent of the present invention can constitute a hair deformation agent by itself, in which case, the fixation of the shape of the hair after application of the first hair deformation agent is in the air. Performed by oxidation with oxygen. Moreover, the 1st agent for hair deformation of this invention can also be used in combination with the 2nd agent for hair deformation, and can also comprise a hair deformation agent (hair deformation agent of this invention) combining these. Examples of the second hair deformation agent that can be combined with the first hair deformation agent of the present invention include the following.
本発明に係る毛髪変形用第２剤は、少なくとも酸化剤が配合されたものである。 The second agent for deforming hair according to the present invention contains at least an oxidizing agent.
酸化剤には、従来から知られているパーマネントウェーブ用剤や縮毛矯正用剤といった毛髪変形剤に用いられている酸化剤が使用できる。酸化剤の具体例としては、過酸化水素、臭素酸ナトリウムなどが挙げられる。毛髪変形用第２剤における酸化剤の配合量は、過酸化水素の場合には、例えば、１〜２．５質量％であることが好ましい。また、臭素酸ナトリウムの場合には、例えば、５〜１５質量％であることが好ましい。 As the oxidizing agent, conventionally known oxidizing agents used for hair deforming agents such as permanent wave agents and hair straightening agents can be used. Specific examples of the oxidizing agent include hydrogen peroxide and sodium bromate. In the case of hydrogen peroxide, the blending amount of the oxidizing agent in the second hair deformation agent is preferably 1 to 2.5% by mass, for example. Moreover, in the case of sodium bromate, it is preferable that it is 5-15 mass%, for example.
また、毛髪変形用第２剤には、従来から知られている毛髪変形剤（パーマネントウェーブ用剤、縮毛矯正用剤）や、その他の毛髪用の化粧剤などに添加されている各種添加剤を配合することができる。このような添加剤としては、例えば、油脂、シリコーン類、高級アルコール、水溶性高分子、保湿剤、界面活性剤、低級アルコール、キレート剤、抗炎症剤、防腐剤、ｐＨ調整剤、紫外線吸収剤、香料などが挙げられる。これらのうち、油脂、シリコーン類、高級アルコール、水溶性高分子、保湿剤、キレート剤、抗炎症剤、防腐剤ｐＨ調整剤および紫外線吸収剤については、毛髪変形用第１剤に配合・添加可能なものとして先に例示した各種材料と同じものを使用することができる。 In addition, the second agent for deforming hair includes various additives added to conventionally known hair deforming agents (permanent wave agents, curly hair straighteners) and other hair cosmetic agents. Can be blended. Examples of such additives include oils and fats, silicones, higher alcohols, water-soluble polymers, humectants, surfactants, lower alcohols, chelating agents, anti-inflammatory agents, antiseptics, pH adjusters, and UV absorbers. And fragrances. Of these, oils, silicones, higher alcohols, water-soluble polymers, moisturizers, chelating agents, anti-inflammatory agents, preservative pH adjusters, and UV absorbers can be added and added to the first hair deformation agent. In addition, the same materials as those exemplified above can be used.
界面活性剤としては、各種の、カチオン性界面活性剤、アニオン性界面活性剤、非イオン性界面活性剤および両性界面活性剤が使用でき、具体的には、毛髪変形用第１剤に配合・添加可能なものとして先に例示した各種材料と同じものを使用することができる。 As the surfactant, various cationic surfactants, anionic surfactants, nonionic surfactants and amphoteric surfactants can be used. Specifically, the surfactant is blended with the first agent for hair deformation. The same materials as those exemplified above as those that can be added can be used.
毛髪変形用第２剤も、毛髪変形用第１剤と同様に水を主たる分散媒とする。なお、前記の各種成分の一部は水に溶解していてもよい。また、分散媒には、水のみを使用してもよく、必要に応じて、エタノール、イソプロパノールなどの低級アルコール（炭素数が６以下のアルコール）などの有機溶媒を、分散媒全量中５質量％以下程度の量で水と併用してもよい。また、毛髪変形用第２剤における分散媒の配合量は、例えば、６０〜９８質量％であることが好ましい。 Similarly to the first agent for deforming hair, the second agent for deforming hair uses water as the main dispersion medium. Note that some of the various components may be dissolved in water. Further, only water may be used as the dispersion medium. If necessary, an organic solvent such as lower alcohol (alcohol having 6 or less carbon atoms) such as ethanol and isopropanol is used in an amount of 5% by mass based on the total amount of the dispersion medium. You may use together with water in the following quantity. Moreover, it is preferable that the compounding quantity of the dispersion medium in the 2nd agent for hair deformation is 60-98 mass%, for example.
毛髪変形用第２剤は、クリーム状、ローション状、ゲル状などの形態とすることができる。 The second agent for deforming hair can be in the form of cream, lotion, gel or the like.
なお、上記の通り、本発明の毛髪変形剤には、パーマネントウェーブ用剤と縮毛矯正用剤とが含まれるが、より具体的には、例えば、パーマネントウェーブ用剤としては、常温で毛髪にウェーブを付与するための、いわゆるコールド式パーマネントウェーブ用剤、加温下で毛髪にウェーブを付与するための、いわゆる加温式パーマネントウェーブ用剤が挙げられ、また、縮毛矯正用剤としては、常温で縮毛をストレートに伸ばして矯正するための、いわゆるコールド式縮毛矯正用剤、加温下で縮毛をストレートに伸ばして矯正するための、いわゆる加温式縮毛矯正用剤、更には高温整髪用アイロンを使用する加温式縮毛矯正用剤が挙げられる。そして、このような用途に応じて先に示した各種配合成分から適当なものを選択し、公知のパーマネントウェーブ用剤や縮毛矯正用剤の調製方法と同様の方法で第１剤および第２剤を調製して、本発明の毛髪変形剤を得ることができる。 As described above, the hair deforming agent of the present invention includes a permanent wave agent and a hair straightening agent. More specifically, for example, as a permanent wave agent, So-called cold-type permanent wave agent for imparting wave, so-called warm-type permanent wave agent for imparting wave to hair under heating, and as a curly hair straightening agent, So-called cold hair straightening agent for straightening and straightening curly hair at room temperature, so-called warming hair straightening agent for straightening and straightening curly hair under heating, Includes a warming hair straightening agent using a high-temperature hair-styling iron. And according to such a use, a suitable thing is selected from the various compounding components shown previously, and the 1st agent and 2nd by the method similar to the preparation method of a well-known permanent wave agent and a hair straightening agent. An agent can be prepared to obtain the hair deformation agent of the present invention.
本発明の毛髪変形剤を用いて毛髪を処理するにあたっては、毛髪変形用第１剤を毛髪に塗布する工程と、上記毛髪を洗浄する工程と、上記洗浄後の毛髪に毛髪変形用第２剤を塗布する工程とを有する方法が適用できる。なお、上記毛髪変形処理方法における具体的な操作・条件については、従来から知られているパーマネントウェーブ用剤や縮毛矯正用剤による処理方法と同じ操作・条件が採用できる。 In treating hair using the hair deforming agent of the present invention, a step of applying a first hair deformation agent to the hair, a step of washing the hair, and a second agent for hair deformation of the washed hair The method which has a process of apply | coating can be applied. In addition, about the specific operation and conditions in the said hair deformation processing method, the same operation and conditions as the processing method by the conventionally known permanent wave agent and the curly hair straightening agent are employable.
より具体的には、例えば、以下のようにすることができる。まず、毛髪変形用第１剤を毛髪に塗布し、ある程度の時間（例えば５〜３０分）放置して、毛髪を十分に軟化させる。 More specifically, for example, the following can be performed. First, the first agent for deforming hair is applied to the hair and left for a certain period of time (for example, 5 to 30 minutes) to sufficiently soften the hair.
続いて、上記放置後の毛髪を洗浄する。毛髪の洗浄は、例えば、水を入れたスポイトなどを用いて行ってもよく、また、流水を用いた洗浄の後に、溜めすすぎ（シャンプー台などの槽に、毛髪量に対して十分な量の水を溜め、その中で毛髪をすすぐこと）を行ってもよい。 Subsequently, the hair after being left standing is washed. For example, the hair may be washed using a dropper filled with water, and after washing with running water, a rinsing rinse (a shampoo table or other tank with a sufficient amount for the amount of hair). Reserving water and rinsing hair in it) may be performed.
次に、上記洗浄後の毛髪に、毛髪変形用第２剤を塗布し、ある程度の時間（例えば５〜１５分）放置する。その後、毛髪から第２剤を流水などで洗い流し、通常はその後にヘアコンディショナーのような後処理剤を毛髪に塗布して軽くすすぎ、乾燥させて仕上げる。 Next, the second agent for hair deformation is applied to the washed hair and left for a certain period of time (for example, 5 to 15 minutes). Thereafter, the second agent is washed away from the hair with running water, and usually a post-treatment agent such as a hair conditioner is applied to the hair, rinsed lightly, and dried to finish.
なお、縮毛矯正処理の場合には、毛髪変形用第１剤を塗布した毛髪や、毛髪変形用第２剤を塗布した毛髪に、ストレート形状を付与するためのコーミングを行ってから、上記の放置を行うことが好ましい。また、整髪用アイロンを用いて矯正する工程を設ける場合には、毛髪変形用第２剤の塗布前に毛髪を乾燥させてからアイロン処理を行う。 In the case of straightening treatment, after combing for imparting a straight shape to the hair coated with the first agent for deforming hair or the hair coated with the second agent for deforming hair, the above-mentioned treatment is performed. It is preferable to leave it as it is. Moreover, when providing the process of correcting using the hair-styling iron, ironing is performed after drying hair before application | coating of the 2nd agent for hair deformation.
また、コールド式パーマネントウェーブ処理の場合には、例えば、ロッドに巻き付けた毛髪に毛髪変形用第１剤を塗布し、そのままの状態で、放置、洗浄、および毛髪変形用第２剤の塗布を行うことができる。更に、加温式パーマネントウェーブ処理の場合には、毛髪変形用第１剤を塗布し、放置してから洗浄した後の毛髪をロッドに巻き付け、ある程度の時間加熱した後に、毛髪変形用第２剤の塗布を行うことができる。 In the case of cold-type permanent wave treatment, for example, the first agent for deforming hair is applied to the hair wound around the rod, and then left, washed, and the second agent for deforming hair is applied as it is. be able to. Furthermore, in the case of the warming-type permanent wave treatment, the first agent for deforming hair is applied, and the hair after washing after being left standing is wound around the rod, heated for a certain period of time, and then the second agent for deforming hair. Can be applied.
以下、実施例に基づいて本発明を詳細に述べる。ただし、下記実施例は本発明を制限するものではない。なお、以下の実施例などにおいて、「％」は「質量％」を意味している。また、毛髪変形用第１剤の配合量としては、全体で１００％となるように各成分の配合量を％で示し、後記の表１、表３〜表６中ではその％の表示を省略し、配合量を表す数値のみで表示する。 Hereinafter, the present invention will be described in detail based on examples. However, the following examples do not limit the present invention. In the following examples, “%” means “mass%”. In addition, as the blending amount of the first agent for deforming hair, the blending amount of each component is expressed in% so that it becomes 100% as a whole, and the display of% is omitted in Tables 1 and 3 to 6 below. And only the numerical value indicating the blending amount is displayed.
実施例１〜６および比較例１
実施例１〜６および比較例１の毛髪変形用第１剤を、表１に示す組成で調製した。
Examples 1 to 6 and Comparative Example 1
The first hair deformation agents of Examples 1 to 6 and Comparative Example 1 were prepared with the compositions shown in Table 1.
なお、表１における水の欄の「計１００とする」とは、毛髪変形用第１剤を構成する水以外の各成分の合計量に、水の量を加えて１００％となるようにしたことを意味している（後記の表３〜表６も同様である）。 In addition, “with a total of 100” in the column of water in Table 1 is 100% by adding the amount of water to the total amount of each component other than water constituting the first agent for deforming hair. (The same applies to Tables 3 to 6 below.)
実施例１〜６および比較例１の毛髪変形用第１剤について、グアイアズレンスルホン酸ナトリウムに起因する５８０ｎｍ付近の極大吸収波長における吸光度を、島津製作所製「ＵＶ−１６００」を用いて測定した。上記の吸光度測定は調製直後および冷暗所で２週間保存後に行い、これらの結果から下記式に基づいてグアイアズレンスルホン酸ナトリウムの残存量を求めた。
残存量（％）＝１００×（２週間保存後の吸光度）／（調製直後の吸光度）
About the 1st agent for hair deformation of Examples 1-6 and the comparative example 1, the light absorbency in the maximum absorption wavelength of 580 nm vicinity resulting from a sodium guaiazulenesulfonate was measured using "UV-1600" by Shimadzu Corporation. The above absorbance measurement was performed immediately after preparation and after storage for 2 weeks in a cool dark place. From these results, the residual amount of sodium guaiazulene sulfonate was determined based on the following formula.
Residual amount (%) = 100 × (absorbance after storage for 2 weeks) / (absorbance immediately after preparation)
上記のようにして求めた各毛髪変形用第１剤におけるグアイアズレンスルホン酸ナトリウムの残存量を、下記基準によって評価した。これらの結果を表２に示す。なお、○、○○、および○○○の評価にものであれば、目視でもグアイアズレンスルホン酸ナトリウム由来の色味を確認できるため、毛髪変形用第１剤を貯蔵した後にも、グアイアズレンスルホン酸ナトリウム由来の色を良好に保持できているといえる。
○○○ ： 残存率が９０％以上。
○○ ： 残存率が７０％以上９０％未満。
○ ： 残存率が６０％以上７０％未満。
× ： 残存率が６０％未満。
The residual amount of sodium guaiazulene sulfonate in each first hair deformation agent determined as described above was evaluated according to the following criteria. These results are shown in Table 2. In addition, since the color derived from sodium guaiazulene sulfonate can be visually confirmed as long as it is an evaluation of ◯, XX, and XX, sodium guaiazulene sulfonate even after storing the first agent for hair deformation It can be said that the color of origin can be kept favorable.
OO: Remaining rate is 90% or more.
○○: Residual rate is 70% or more and less than 90%.
○: Residual rate is 60% or more and less than 70%.
X: Residual rate is less than 60%.
表２から明らかなように、実施例１〜６の毛髪変形用第１剤は、２週間の保存後においても、グアイアズレンスルホン酸ナトリウム由来の色を良好に保持できている。なお、カチオン性界面活性剤を配合していない比較例１の毛髪変形用第１剤は、２週間の保存後には残存率は４３％であるが、目視では無色透明に変色しており、グアイアズレンスルホン酸ナトリウム由来の色が消失していた。 As is apparent from Table 2, the first agent for deforming hair of Examples 1 to 6 can keep the color derived from sodium guaiazulene sulfonate well even after storage for 2 weeks. The first hair deformation agent of Comparative Example 1 containing no cationic surfactant had a residual rate of 43% after storage for 2 weeks, but was visually transparent and discolored, and guaiazulene The color derived from sodium sulfonate disappeared.
実施例７〜１０および比較例２〜１１
実施例７〜１０および比較例２〜１１の毛髪変形用第１剤を、表３〜表５に示す組成で調製した。また、比較のために、グアイアズレンスルホン酸ナトリウムおよびキレート剤のみを水に溶解させた参考例１、参考例１の水溶液に更にアルカリ剤を溶解させた参考例２、および参考例１の水溶液に更に還元剤を溶解させた参考例３も、表６に示す組成で調製した。
Examples 7 to 10 and Comparative Examples 2 to 11
The 1st agent for hair deformation of Examples 7-10 and Comparative Examples 2-11 was prepared with the composition shown in Tables 3-5. For comparison, reference example 1 in which only sodium guaiazulenesulfonate and a chelating agent were dissolved in water, reference example 2 in which an alkaline agent was further dissolved in the aqueous solution in reference example 1, and the aqueous solution in reference example 1 were further added. Reference Example 3 in which the reducing agent was dissolved was also prepared with the composition shown in Table 6.
なお、表４に記載の「ＰＯＥ（２５）セチルエーテル」および「ＰＯＥ（２）ラウリル硫酸ナトリウム」における「ＰＯＥ」は「ポリオキシエチレン」の略であり、ＰＯＥの後の括弧内の数値は、酸化エチレンの平均付加モル数である。また、表５に記載の「ＰＥＧ１０００」および「ＰＥＧ６０００」の「ＰＥＧ」は「ポリエチレングリコール」の略であり、「ＰＥＧ」の後の数値は、その数平均分子量である。 In addition, “POE” in “POE (25) cetyl ether” and “POE (2) sodium lauryl sulfate” described in Table 4 is an abbreviation of “polyoxyethylene”, and the numerical value in parentheses after POE is It is the average number of moles of ethylene oxide added. In addition, “PEG” in “PEG1000” and “PEG6000” shown in Table 5 is an abbreviation for “polyethylene glycol”, and the numerical value after “PEG” is the number average molecular weight.
実施例７〜１０、および比較例２〜１１の毛髪変形用第１剤、並びに参考例１〜３の水溶液について、実施例１〜６および比較例１の毛髪変形用第１剤と同様に冷暗所で２週間保存し、その後の色を、下記の基準に従って目視で評価した。これらの結果を表７に示す。 About the 1st agent for hair deformation of Examples 7-10 and Comparative Examples 2-11, and the aqueous solution of Reference Examples 1-3, it is a cool dark place like Examples 1-6 and the 1st agent for hair deformation of Comparative Example 1. And stored for 2 weeks, and the subsequent color was visually evaluated according to the following criteria. These results are shown in Table 7.
○○○ ： その色が、実施例４〜６の毛髪変形用第１剤と同等である。
○○ ： その色が、実施例３の毛髪変形用第１剤と同等である。
○ ： その色が、実施例１、２の毛髪変形用第１剤と同等である。
× ： その色が、比較例１の毛髪変形用第１剤と同等である。
OO: The color is equivalent to the first agent for hair deformation of Examples 4-6.
◯: The color is equivalent to the first agent for hair deformation of Example 3.
○: The color is equivalent to the first agent for hair deformation of Examples 1 and 2.
X: The color is equivalent to the 1st agent for hair deformation of the comparative example 1.
表７から明らかなように、実施例７〜１０の毛髪変形用第１剤は、２週間の保存後における色が、実施例４〜６の毛髪変形用第１剤と同等であり、グアイアズレンスルホン酸ナトリウム由来の色を良好に保持できている。これに対し、カチオン性界面活性剤を使用せずに他の界面活性剤などを配合した比較例２〜１１の毛髪変形用第１剤は、比較例１の毛髪変形用第１剤と同様に、２週間の保存後にはグアイアズレンスルホン酸ナトリウム由来の色が消失し、無色透明となっていた。 As is clear from Table 7, the first hair deformation agent of Examples 7 to 10 has the same color after storage for 2 weeks as the first agent for hair deformation of Examples 4 to 6, and guaiazulene sulfone. The color derived from sodium acid is well maintained. On the other hand, the 1st agent for hair deformation of Comparative Examples 2-11 which mix | blended other surfactant etc. without using cationic surfactant is the same as the 1st agent for hair deformation of Comparative Example 1 similarly. After storage for 2 weeks, the color derived from sodium guaiazulenesulfonate disappeared and became colorless and transparent.
なお、参考例１〜３の水溶液のうち、還元剤を配合していない参考例１、２の水溶液では、２週間の保存後における色が実施例４〜６の毛髪変形用第１剤と同等で、グアイアズレンスルホン酸ナトリウム由来の色が良好に保持されているのに対し、還元剤を配合した参考例３の水溶液では、２週間の保存後における色が比較例１の毛髪変形用第１剤と同等で、グアイアズレンスルホン酸ナトリウム由来の色が消失した。よって、毛髪変形用第１剤におけるグアイアズレンスルホン酸ナトリウム由来の色の変化は、還元剤の存在に起因するものであり、還元剤を配合していない液剤における色の変化とは異なる反応によって生じていると推測される。 In addition, among the aqueous solutions of Reference Examples 1 to 3, in the aqueous solutions of Reference Examples 1 and 2 that did not contain a reducing agent, the color after storage for 2 weeks was equivalent to the first agent for hair deformation of Examples 4 to 6 In contrast, while the color derived from sodium guaiazulene sulfonate is well maintained, in the aqueous solution of Reference Example 3 containing a reducing agent, the color after storage for 2 weeks is the first agent for hair deformation of Comparative Example 1 The color derived from sodium guaiazulene sulfonate disappeared. Therefore, the color change derived from sodium guaiazulenesulfonate in the first hair deformation agent is caused by the presence of the reducing agent, and is caused by a reaction different from the color change in the liquid preparation not containing the reducing agent. It is estimated that
なお、実施例１〜１０の毛髪変形用第１剤のそれぞれと、８％濃度の臭素酸ナトリウム水溶液からなる毛髪変形用第２剤とを組み合わせて、実施例１１〜２０の毛髪変形剤を構成した。そして、同一人から毛髪を採取して複数の毛束を用意し、各毛髪変形剤に係る毛髪変形用第１剤を、それぞれ別の毛束に塗布し、１０分放置後に水で中間洗浄を行い、続いて各毛束に毛髪変形用第２剤を塗布して１０分放置し、その後に各毛束を水ですすぎ、トリートメントを塗布し、洗い流してからドライヤーで乾燥させる手順で毛髪変形処理を施した。その結果、いずれの毛髪変形剤でも、変形処理を良好に行い得ることが確認できた。 In addition, the hair deformation agent of Examples 11-20 is comprised combining each 1st agent for hair deformation of Examples 1-10 and the 2nd agent for hair deformation which consists of 8% concentration sodium bromate aqueous solution. did. Then, hair is collected from the same person to prepare a plurality of hair bundles, and the first hair deformation agent according to each hair deforming agent is applied to each of the different hair bundles, and left for 10 minutes, followed by intermediate washing with water. Next, apply the second hair deformation agent to each hair bundle and leave it for 10 minutes, then rinse each hair bundle with water, apply the treatment, wash it off and dry it with a dryer. Was given. As a result, it was confirmed that any hair deforming agent can be satisfactorily deformed.
Claims (4)
（ａ）グアイアズレンスルホン酸塩、
（ｂ）還元剤、
（ｃ）アルカリ剤、
（ｄ）カチオン性界面活性剤、および
（ｅ）キレート剤
が配合され、上記（ｂ）還元剤としてチオグリコール酸またはその塩が配合されており、
（ｄ）カチオン性界面活性剤の配合量が、モル基準で、（ａ）グアイアズレンスルホン酸塩の配合量１に対して、１以上であり、
（ａ）グアイアズレンスルホン酸塩の配合量が、０．０５質量％以下であることを特徴とする毛髪変形用第１剤。 at least,
(A) guaiazulene sulfonate,
(B) a reducing agent,
(C) alkaline agent,
(D) a cationic surfactant, and (e) a chelating agent, and (b) thioglycolic acid or a salt thereof as a reducing agent.
(D) the amount of the cationic surfactant, on a molar basis, relative to the amount 1 (a) guaiazulene sulfonate state, and are 1 or more,
(A) the amount of guaiazulene sulfonate, first agent for hair deformation, characterized in der Rukoto 0.05 mass% or less.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010031064A JP5850517B2 (en) | 2010-02-16 | 2010-02-16 | First agent for hair deformation and hair deformation agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010031064A JP5850517B2 (en) | 2010-02-16 | 2010-02-16 | First agent for hair deformation and hair deformation agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011168499A JP2011168499A (en) | 2011-09-01 |
| JP5850517B2 true JP5850517B2 (en) | 2016-02-03 |
Family
ID=44683002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010031064A Active JP5850517B2 (en) | 2010-02-16 | 2010-02-16 | First agent for hair deformation and hair deformation agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5850517B2 (en) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51125713A (en) * | 1974-12-27 | 1976-11-02 | Sawai Seiyaku Kk | A process for preparing 1,4-dimethyl-7- isopropylazulene-3-sulfonate q uaternary ammonium salt |
| JPS62298516A (en) * | 1986-06-16 | 1987-12-25 | Sakamoto Kouseidou:Kk | Production of permanent wave solution |
| JPH0735342B2 (en) * | 1986-08-20 | 1995-04-19 | ライオン株式会社 | Azulene-containing liquid |
| JP2528646B2 (en) * | 1987-01-30 | 1996-08-28 | 株式会社資生堂 | Treatment agent for hair deformation |
| JPH01121216A (en) * | 1987-11-06 | 1989-05-12 | Taiho Yakuhin Kogyo Kk | Stable drug preparation containing sodium guaiazulenesulfonate |
| JPH0543423A (en) * | 1991-08-14 | 1993-02-23 | Kao Corp | Hair treating agent composition |
| JP3261690B2 (en) * | 1994-11-17 | 2002-03-04 | 株式会社資生堂 | Permanent wave agent 1st agent |
| JP3733546B2 (en) * | 1998-03-05 | 2006-01-11 | 株式会社日本点眼薬研究所 | Azulene aqueous liquid |
| JP2001097834A (en) * | 1999-09-30 | 2001-04-10 | Yamahatsu Sangyo Kk | Aerosol product filled with hair dye composition |
| JP2003128537A (en) * | 2001-08-15 | 2003-05-08 | Rohto Pharmaceut Co Ltd | Stabilized composition |
| JP3969587B2 (en) * | 2003-12-12 | 2007-09-05 | 本草製薬株式会社 | Azulene sulfonate sodium preparation |
| JP2008127380A (en) * | 2006-11-20 | 2008-06-05 | Estate Chemical Kk | Hair treatment preparation |
-
2010
- 2010-02-16 JP JP2010031064A patent/JP5850517B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011168499A (en) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10456341B2 (en) | Compositions and methods for simultaneous reshaping and direct coloring of hair | |
| JP2016539933A (en) | Semi-permanent hair straightening composition and method | |
| RU2760684C1 (en) | Method for processing material including amine salt of carboxylic acid having from 4 to 10 carbon atoms | |
| US10463589B2 (en) | Hair dye composition | |
| KR20130008565A (en) | Hair styling composition | |
| JP5844039B2 (en) | Perm second agent and hair straightener kit | |
| JP4925156B2 (en) | First agent for straightening hair, agent for straightening hair, and method for straightening curly hair | |
| JP5219234B2 (en) | Hair treatment agent | |
| JP5517430B2 (en) | Hair deformation second agent, hair deformation agent, and hair deformation treatment method | |
| EP3506877B1 (en) | Concentrate for keratin fiber treatment compositions | |
| JP5850517B2 (en) | First agent for hair deformation and hair deformation agent | |
| JP5714233B2 (en) | Hair deformation agent | |
| JP5582735B2 (en) | Hair cosmetics | |
| JP5919026B2 (en) | Pretreatment agent, permanent hair treatment agent, and hair treatment method | |
| JP6522571B2 (en) | Hair treatment agent and hair penetration enhancer | |
| JP5190982B2 (en) | Emulsified hair cosmetic composition, second agent for straightening hair, agent for straightening hair, and method for treating hair | |
| EP3290019B1 (en) | Hair treatment method | |
| JP2019059796A (en) | Hair treatment agent and hair permeation promoter | |
| KR101991972B1 (en) | Hair treatment agent | |
| JP6983505B2 (en) | A composition containing glutaric acid and at least one aromatic alcohol for treating keratin fibers. | |
| JP5495631B2 (en) | First agent for hair deformation and hair deformation agent | |
| JP5582547B2 (en) | Hair deformation agent | |
| WO2021131915A1 (en) | Fiber treatment agent composition | |
| JP2020200257A (en) | First agent for hair deforming, and hair deforming method | |
| JP6081077B2 (en) | Oxidative hair dye |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130118 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140213 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140828 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20141021 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20141024 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141125 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150602 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150825 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150901 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151127 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151127 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5850517 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |